https://biotechmorning.com/news/shionogi-intrabio-2-billion-rare-disease-acquisition-2 Biotech Morning en 2026-10-19T14:12:44.375Z Shionogi Just Bet $2 Billion on a Disease Most People Have Never Heard Of https://biotechmorning.com/news/bitopertin-apollo-epp-trial-results Biotech Morning en 2026-10-19T14:11:57.932Z Roche's Failed Schizophrenia Drug Just Aced a Trial for a Rare Disease https://biotechmorning.com/news/roche-hansoh-second-adc-deal Biotech Morning en 2026-10-19T14:11:08.813Z Roche Just Went Back for Seconds in China https://biotechmorning.com/news/nouscom-135-million-cancer-vaccine Biotech Morning en 2026-10-19T14:10:20.120Z $135 Million to Stop Cancer Before It Starts https://biotechmorning.com/news/viatris-pacira-acquisition-non-opioid-pain Biotech Morning en 2026-10-19T14:09:37.435Z Viatris Just Paid a 45% Premium to Break Up With Generics https://biotechmorning.com/news/gilead-crashes-ibd-party-ulcerative-colitis Biotech Morning en 2026-10-19T14:08:50.559Z Gilead Just Crashed the Biggest Party in Gastroenterology https://biotechmorning.com/news/abbvie-abbv-466-beats-skyrizi-crohns-disease Biotech Morning en 2026-10-19T14:08:07.412Z AbbVie Just Beat Its Own Blockbuster. On Purpose. https://biotechmorning.com/news/teva-weltruza-schizophrenia-monthly-injection-fda-approval Biotech Morning en 2026-10-18T14:17:59.021Z The Schizophrenia Shot That Ditches the Biggest Safety Headache https://biotechmorning.com/news/roche-billion-dollar-dualitas-bispecific-screening-deal Biotech Morning en 2026-10-18T14:17:07.996Z Roche Is Betting $1 Billion on a Startup That Barely Exists https://biotechmorning.com/news/verastem-kras-g12d-pancreatic-cancer-data Biotech Morning en 2026-10-18T14:16:20.593Z The Cancer Target Nobody Could Hit for 40 Years Just Got Hit Again https://biotechmorning.com/news/undruggable-kras-conquers-europe-pancreatic-cancer Biotech Morning en 2026-10-18T14:15:30.957Z The 'Undruggable' Cancer Target That Just Conquered Europe https://biotechmorning.com/news/intellia-crispr-phase-3-hereditary-angioedema Biotech Morning en 2026-10-18T14:14:45.731Z One Shot to Silence a Disease Forever https://biotechmorning.com/news/astrazeneca-absci-ai-antibody-deal Biotech Morning en 2026-10-18T14:13:58.883Z AstraZeneca Is Letting AI Design Its Next Cancer Drug From Scratch https://biotechmorning.com/news/biontech-mRNA-cancer-vaccine-bnt113-fails-phase-3 Biotech Morning en 2026-10-18T14:13:13.006Z BioNTech Bet Big on mRNA Beating Cancer. The Cancer Won. https://biotechmorning.com/news/once-weekly-achondroplasia-therapy-europe Biotech Morning en 2026-10-18T14:12:28.383Z One Shot a Week Could Change Everything for Kids With Achondroplasia https://biotechmorning.com/news/novartis-fabhalta-lupus-nephritis-trial-halted Biotech Morning en 2026-10-18T14:11:44.020Z Novartis Just Pulled the Plug on Fabhalta's Biggest Ambition https://biotechmorning.com/news/bms-orbital-therapeutics-1-5-billion-acquisition Biotech Morning en 2026-10-18T14:10:55.404Z BMS Just Paid $1.5 Billion for a Company With Zero Approved Drugs https://biotechmorning.com/news/adc-that-couldnt-clear-the-bar Biotech Morning en 2026-10-18T14:10:12.303Z The ADC That Couldn't Clear the Bar